Skip to main content
Premium Trial:

Request an Annual Quote

Promega, CDI Collaborate on Stem Cell-Based Drug Toxicity Assays

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stem cell technology company Cellular Dynamics International and Madison, Wisconsin-based life sciences company Promega today announced plans to collaborate on validating predictive drug discovery toxicity tests that rely on CDI's induced pluripotent stem cells and cytotoxicity and cell viability assays from Promega.

Through the collaboration, the companies plan to combine CDI's iCell Cardiomyocytes — human heart muscle cells derived from induced pluripotent stem cells — with Promega bioassays to come up with a validated, stem cell-based in vitro assay for predicting dangerous or unwanted side effects during the drug discovery and development process.

CDI, a spinout of the University of Wisconsin at Madison, says it has validated a Promega cell-based cytotoxicity assay using the iCell Cardiomyocytes and presented data at scientific conferences supporting the use of Promega's multiplexed biomarker cytotoxicity and cell viability assays for recognizing toxic agents.

CDI and its collaborators in the pharmaceutical industry will reportedly continue testing and validating Promega assays in the hopes of making them part of their drug discovery programs.

In a statement issued today, CDI Chief Commercial Officer Chris Parker said the CDI-Promega collaboration should lead to safer and more effective drug development that hinges on biologically predictive data.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.